Now showing items 1-4 of 4
Comparative Legal Review: Reassessing the Social Contract in Europe and the United States for Patenting Human Genetic Materials
(Queen Mary University of London, 2015-01-26)
In 2013, the US Supreme Court declared isolated gene sequences as ‘products of nature’ and hence, unpatentable subject matter. Paradoxically, the European Patent Office (EPO), relying on the EU Biotech Directive 98/44/EC, ...
The International Trade: Dispute over GMO's before the WTO: Causes and Consequences
(Queen Mary University of London, 2014-07-08)
The Biotech dispute at WTO received a great deal of attention, and reopened a wide-ranging debate over the benefits of genetically modified organisms (GMOs) and their effects on human health and the environment. The dispute ...
STIMULATING INNOVATION IN BRAZIL: A STUDY OF INTELLECTUAL PROPERTY LAW, BIOTECHNOLOGY AND OPEN SCIENTIFIC INNOVATION
(Queen Mary University of London, 2017-01-31)
The Agreement on Trade-Related Aspects of Intellectual Property (TRIPS) administered by the World Trade Organization affects a wide range of domestic public policies and industry practices in biotechnology. With the advent ...
An empirical study on biotechnology and intellectual property rights: the case for open scientific innovation in Brazil
(Queen Mary University of London, 2013-09)
This thesis investigates the interaction between biotechnology, intellectual property rights and Open Scientific Innovation (OSI). The current intellectual property rights - dependent business models prevailing within the ...